Scientists find clues on why COVID vaccine causes chronic health problems in some
Yale researchers recently made some discoveries about why certain people experience this condition, which they have dubbed "post-vaccination syndrome" (PVS).
In early findings, the team recognized "potential immunological patterns" that are unique to people with PVS. The hope is that this discovery will help to enable future treatments and therapies for those who are affected.
"This work is still in its early stages, and we need to validate these findings," said co-senior study author Akiko Iwasaki, Sterling Professor of Immunobiology at Yale School of Medicine, in a press release.
"But this is giving us some hope that there may be something that we can use for diagnosis and treatment of PVS down the road."
People with this condition may suffer from excessive fatigue, exercise intolerance, brain fog, insomnia and dizziness, according to the Yale researchers.
These typically develop within a day or two of vaccination and can worsen over time.
"It's clear that some individuals are experiencing significant challenges after vaccination. Our responsibility as scientists and clinicians is to listen to their experiences, rigorously investigate the underlying causes, and seek ways to help," said co-senior author Harlan Krumholz, professor of cardiology at YSM, in the release.
"Post-vaccination syndrome is real, and has been found [to occur] from many vaccines, including COVID," Dr. Marc Siegel, clinical professor of medicine at NYU Langone Health and Fox News senior medical analyst, told Fox News Digital.
The researchers analyzed blood samples from 42 study participants who experienced symptoms of PVS and 22 who did not.
Those with symptoms were shown to have lower levels of two types of white blood cells. People with PVS who had never had COVID also had lower levels of antibodies against the SARS-CoV-2 spike protein, likely because they tended to have fewer vaccine doses, according to the release.
"Post-vaccination syndrome is real, and has been found [to occur] from many vaccines."
"Fewer vaccine doses and no viral infection means the body's immune system has had little opportunity to develop a defense to the virus," said the researchers.
Some of the people with PVS also had higher levels of the SARS-CoV-2 spike protein, which enables the virus to penetrate and infect host cells. This has also been linked to a higher risk of developing long COVID.
"We don't know if the level of spike protein is causing the chronic symptoms, because there were other participants with PVS who didn't have any measurable spike protein — but it could be one mechanism underlying this syndrome," said Iwasaki.
In addition to the elevated spike proteins, other factors could increase the risk of post-vaccination syndrome. Those include autoimmunity, tissue damage and reactivation of Epstein-Barr virus (EBV), the researchers wrote.
"Akiko Iwasaka is a world-renowned immunologist at Yale who has studied COVID (and COVID vaccines) extensively," Siegel pointed out.
"In this new study, she reports that in a very small percentage of those who received COVID vaccines (and experienced prolonged side effects), there may be the presence of persistent spike protein," Siegel confirmed.
"They may also experience immune disruption, which takes the form of elevations in inflammatory immune cells (CD8 and TN alpha) and a decrease in cells that help resolve inflammation and infection (CD4 helper cells)."
The researchers agreed that more studies are essential to guide diagnosis and treatment.
"We're only just starting to make headway in understanding PVS," said Krumholz. "Every medical intervention carries some risk, and it's important to acknowledge that adverse events can occur with vaccines."
For more Health articles, visit www.foxnews.com/health
"Our focus must remain on understanding what these people are experiencing through rigorous science and addressing the needs of those affected with compassion and an open mind."
Siegel agreed, adding, "This needs to be further studied in terms of understanding how common prolonged COVID vaccine side effects are and how to predict them and treat them."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
an hour ago
- The Hill
Most adults do not plan on getting COVID-19 shot amid vaccine policy changes
More than half of American adults — 59 percent — say they do not expect to get the COVID-19 booster shot this autumn, according to new poll findings from healthcare policy group KFF. Poll results show that 23 percent of U.S. adults say they will 'probably not' get the vaccine, while 37 percent will 'definitely not' get the shot. Americans who said they will 'probably' or 'definitely' not get the shot were also more likely to say they think changes to U.S. vaccine policy are 'major' and will make people less safe. The data comes as the Trump administration makes drastic changes to the country's vaccine policy. Secretary for the Department of Health and Human Services Robert F. Kennedy Jr. announced earlier this year that the COVID-19 shot will no longer be recommended for healthy children and pregnant women. Kennedy also abruptly fired all 17 members of an independent vaccine advisory panel for the Centers for Disease Control and Prevention in June. He then replaced the panel with eight hand-picked appointees, many of whom have expressed vaccine skepticism in the past. Adults who identify as Republicans are far less likely to plan on getting the vaccine compared to those who identify as Democrats. About six out of 10 Republicans said they would 'definitely not' get the shot compared to about one out of 10 Democrats, according to the poll. White adults are the most likely to say that they are against getting the vaccine once the colder months arrive with about four out of 10 admitting they will 'definitely not' get the shot. Meanwhile, 32 percent of Black adults say they will 'definitely not' get the COVID-19 vaccine this fall, along with 30 percent of adults who identify as Hispanic. Adults between the ages of 30 and 49 are the most likely to say that they do not plan on getting the vaccine, with 42 percent of that age group saying they will 'definitely not' get the shot in the fall. The U.S. appears to be experiencing another summer wave of COVID-19 cases. As of July 29, COVID-19 infections are growing or likely growing in 40 states, including Florida, Texas, and New York, according to the CDC. The KFF poll was conducted via a national representative survey of about 1,300 people between July 8-14.
Yahoo
an hour ago
- Yahoo
New Nimbus & Stratus COVID Variants Are Spreading—Here's Why Midlife Women Should Be Concerned
If it seems like more people have been getting COVID-19 lately, it's not your imagination. According to the Centers for Disease Control and Prevention (CDC), infections are increasing, or likely increasing, in more than half of the states—and they're not declining in any. At the moment, two new strains of the virus—Nimbus and Stratus—are making the rounds. Both appear to be derivatives of the omicron strain, says Dr. Daniel Egan, an infectious disease physician at Orlando Health. More from Flow Space Is There Really About to Be a Breast Cancer Vaccine? A key symptom of the Nimbus strain is a severe sore throat that many are calling 'razor blade throat,' says Dr. Bernadette Boden-Albala, an epidemiologist and the director and founding dean of the UC Irvine Joe C. Wen School of Population & Public Health. 'This very sore throat is also associated with a raspy or strained voice,' she explains. 'Other common symptoms mirror previous COVID strains like runny nose, headache, difficulty breathing and fatigue.' After contracting COVID in late June, I can confirm that 'razor blade throat' is an accurate descriptor for what you experience with this strain. It felt like there were sharp knives lining the inside of my throat, which was the symptom that prompted me to take a COVID test in the first place—especially with the rise in cases this summer. But this isn't like the summer waves of the past few years, when COVID vaccines were readily available to everyone. In May, Food and Drug Administration (FDA) officials announced that annual COVID-19 boosters will be limited to people aged 65 and older, and those with certain medical conditions that put them at high risk for severe infection. This new policy leaves millions of midlife women without up-to-date protection from the vaccine. Not only that, but the threat of long COVID very much still exists—especially for women. In fact, a recently published peer-reviewed study found that women had a three-fold higher risk of being diagnosed with long COVID, and the risk rises more with age. Here's what to know about this year's summer COVID wave and why midlife women should be concerned. What Is Causing COVID Cases to Spike? The Nimbus and Stratus variants have mutations that help them dodge prior immunity, so they spread easily, says Dr. Julio Baute, a physician and the clinical content and evidence-based medicine consultant at Invigor Medical. While these two variants are responsible for the majority of COVID cases in the U.S. this summer, there is no evidence that they're more severe than previous Omicron strains, he explains. Egan says that he's seen a few more cases than usual in his hospital, but overall, he's not seeing infected patients transferred to the ICU. According to Boden-Albala, we're seeing an uptick in COVID-19 cases this summer because of a combination of seasonal factors. 'Just like other respiratory viruses, COVID-19 tends to spread more easily when people are spending more time indoors—often to escape the heat—in close contact with others and in air-conditioned spaces with limited ventilation,' she explains. 'Traveling by air, large gatherings and relaxed precautions also contribute to increased transmission.' On top of that, people tend to ignore their symptoms during the summer, and instead of staying home to recover, they continue on with their activities, potentially getting sicker as well as spreading the virus, Boden-Albala notes. 'While many people have some immunity from past infection or vaccination, the virus continues to evolve, and even mild cases can have serious ripple effects, particularly for those who are immunocompromised or at higher risk,' she adds. What About COVID Vaccines? Here's where things get tricky. Although the FDA no longer recommends COVID boosters for healthy people under the age of 65, Boden-Albala says that 'most pharmacies are still providing vaccine boosters,' so you should check around and get a booster if you haven't had one in a while. According to the World Health Organization, the currently approved COVID-19 vaccines are expected to remain effective against the new variants as far as preventing severe disease. Additionally, vaccination is associated with a lower risk of long COVID, Baute says. That's even more reason to get a booster if you can. Is Long COVID Still a Threat? In short, yes—especially for women, who are disproportionately affected by the constellation of symptoms and conditions. In other words, if you contract COVID, there's still a chance of ending up with long COVID—though staying up-to-date with vaccinations does reduce that risk. A recent study exploring the association between female gender and long COVID syndrome also demonstrated that 'advanced age was associated with ongoing fatigue and musculoskeletal pain, or impairment in pulmonary functions, reflecting a decline in organ function and a slower ability to recover,' Boden-Albala points out. Although it's still unclear why women are more likely to end up with long COVID, this is in line with women being disproportionately impacted by other chronic conditions like ME/CFS, fibromyalgia and multiple sclerosis. 'The scientific community is unraveling the role hormones play in perpetuating the severity of COVID, even after recovery,' Boden-Albala says. According to Baute, sex-based immune responses, hormone influences, differences in autoimmune susceptibility and social factors may contribute to the fact that women are more likely to end up with long COVID than men. 'Evidence is suggestive, not conclusive, but more studies are needed,' he says. As one of the millions of Americans living with long COVID, I can assure you that you don't want to end up with any of the more than 200 symptoms associated with the condition, like constant exhaustion, cognitive issues, exercise intolerance, persistent headaches, sleep disturbances, shortness of breath, a fast or irregular heartbeat, depression and anxiety. While treatments are available to help manage the symptoms, there's currently no cure for long COVID. The best way to avoid long COVID is by not contracting COVID in the first place. How Can Midlife Women Protect Themselves Against COVID? The best way to protect yourself against COVID is to stay up-to-date with your vaccines, if possible, Boden-Albala says. 'The updated COVID-19 vaccines are designed to target circulating variants more effectively,' she explains. 'Staying current offers the best protection against severe illness, especially for people with higher risk factors such as midlife hormonal changes that can impact immunity or pre-existing health conditions.' Even though the FDA is limiting COVID-19 vaccines to those aged 65 and older, there is a way around the new restriction: people with certain risk factors will still be allowed to get regular boosters. The FDA's list of eligible conditions, which was published in the New England Journal of Medicine along with the rest of the guidelines, are exceptionally vague, to the point where many people can claim eligibility based on obesity (BMI of 30 or higher) or 'physical inactivity.' Whether or not you're able to get a COVID booster, Baute recommends layered risk-reduction strategies, like ventilating rooms, masking in crowded indoor spaces during surges, testing early if symptomatic and seeking treatment promptly if you're at higher risk of contracting the infection. Additionally, do what you can to keep your immune system strong. 'Midlife women often juggle caregiving, careers, and hormonal shifts that can strain the immune system,' Boden-Albala says. 'Maintaining a strong baseline of health through proper sleep, exercise, nutrient-rich food and stress reduction can support immune resilience.' Solve the daily Crossword
Yahoo
2 hours ago
- Yahoo
Crews deployed to battle invasive 'vampire fish' in Great Lakes
Crews are out in the field, working to keep sea lamprey populations under control this summer, according to a recent social media post from Fisheries and Oceans Canada: Work began back in April in Lake Erie in Ontario and is expected to continue into October. That's good news, because when left to multiply, sea lampreys can cause big problems and threaten the Great Lake's $5.1 billion fishing industry. Yikes! (Canva) There are four native lamprey species in the Great Lakes - the American brook lamprey, the chestnut lamprey, the silver lamprey, and the northern brook lamprey. The sea lamprey is invasive, and it can devastate local ecosystems. That has a lot to do with its size. Sea lampreys are big compared to naive species -- up to four times bigger. And in the Great Lakes, they have almost unlimited food availability, practically unlimited spawning grounds, and no natural predators. Sea lampreys posing for the camera. (Fernando Losada Rodríguez/Wikipedia) CC BY-SA 4.0 COVID-19 restrictions caused a spike in sea lamprey population COVID-19 safety restrictions paused the ongoing work needed to control sea lamprey populations in the Great Lakes. A March 2025 study found this caused sea lamprey numbers to "skyrocket," highlighting the need for ongoing control measures. Experts say the invasive lampreys can kill more fish than humans in the Great Lakes. Vampire fish Sea lampreys can inflict gruesome damage on their prey, earning these eel-like parasites the nickname "vampire fish." Only about one in seven fish attacked by a sea lamprey will survive. They will suction themselves to a fish, creating a seal that's nearly impossible to break off. They have about 100 teeth, which they use to suction to the side of a fish, and a sharp tongue that drills through its scales. They secret an enzyme that prevents blood from clotting. Once attached, the sea lamprey will spend the next several months feeding off the blood and fluids of the host animal. Lake trout with lampreys attached. (Great Lakes Fishery Commission/Wikipedia) Just in case you're wondering, sea lampreys can accidentally latch on to humans, usually when people are swimming. A bite won't be fatal, but it can be painful, and untreated wounds could lead to infection. Sea lampreys don't pose a threat to people though - they aren't interested in us and human bites appear to be rare. In their native environment, the Atlantic Ocean, sea lampreys don't often kill their host. In the Great Lakes, where sea lampreys have not co-evolved alongside native species, they are a significant threat. Shipping canals transport more than just ships Sea lampreys entered the Great Lakes from the Atlantic Ocean through man-made shipping canals, popping up in Lake Ontario in the 1830s. When the Welland Canal deepened in 1919, sea lampreys gained access to all the Great Lakes -- and they remain there to this day, although their numbers are falling. In the 1950s, the U.S. and Canada teamed up to implement population control measures), and they have worked. Several strategies, including traps to capture adult lampreys, lampricides to target sea lamprey larvae, and installing barriers and traps are a few tactics in use. So far, it's working. Today, sea lamprey populations are down by around 90 per cent in the Great Lakes. Header image: Cheryl Santa Maria for The Weather Network, using elements from Canva Pro and the public domain.
